News

Drug Combination Targets H. pylori


 

Axcan's Pylera 3-in-1 capsules have been approved for the treatment of Heliobacter pylori infection, the main cause of gastric and duodenal ulcers. Each capsule contains 140 mg of biskalcitrate potassium, 125 mg of metronidazole, and 125 mg of tetracycline hydrochloride. The drug, formerly known as Helizide, is administered in combination with two daily doses of 20 mg of omeprazole. For more information, visit the Axcan Web site at www.axcan.com

Recommended Reading

Natalizumab Takes Crohn's Remission Past 2 Years
MDedge Family Medicine
Hydrotherapy Excels as Safe, Tolerable Bowel Prep
MDedge Family Medicine
Alternatives to Traditional Colonoscopy Sought
MDedge Family Medicine
FDA Approves Drug For Colorectal Cancer
MDedge Family Medicine
Eosinophilic Esophagitis Is Enigmatic in Adults
MDedge Family Medicine
Mouth Ulcers and Defects in Tooth Enamel May Suggest Celiac Disease
MDedge Family Medicine
Textbook Celiac Disease Occurs Less Often, Eluding Diagnosis
MDedge Family Medicine
Virtual Colonoscopy Poised To Gain Wide Acceptance
MDedge Family Medicine
Virtual Screening May Reduce Polypectomies
MDedge Family Medicine
Low-Tech Options for Inflammatory Bowel Disease Promising
MDedge Family Medicine